Xu lab:Research: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Peisheng Xu (talk | contribs) (New page: {{Xu_tool}} {|cellspacing="5" cellpadding="10" style="background:#33669c; width: 750px;" |-valign="top" |style="background:#ffffff"| The primary interests of our lab are design and synth...) |
Peisheng Xu (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{Xu_tool}} | {{Xu_tool}} | ||
{|cellspacing="5" cellpadding="10" style="background:# | {|cellspacing="5" cellpadding="10" style="background:#fff5ee; width: 750px;" | ||
|-valign="top" | |-valign="top" | ||
|style="background:# | |style="background:#f5fffa"| | ||
The primary interests of our lab are design and synthesis of biomaterials, and exploring their biomedical applications. The long-term goals of our research are to develop cancer targeted nano-sized drug carrier to eradicate cancer and to design novel drug formulation to alleviate central nervous system (CNS) diseases. Currently, our foci are rational design, and synthesis environment responsive polymers, and fabricating them into cancer or CNS targeted nanoparticle for chemotherapy or gene therapy. | The primary interests of our lab are design and synthesis of biomaterials, and exploring their biomedical applications. The long-term goals of our research are to develop cancer targeted nano-sized drug carrier to eradicate cancer and to design novel drug formulation to alleviate central nervous system (CNS) diseases. Currently, our foci are rational design, and synthesis environment responsive polymers, and fabricating them into cancer or CNS targeted nanoparticle for chemotherapy or gene therapy. | ||
Revision as of 16:23, 5 February 2010
Home ; Research ; Lab Members ; Publications ; Contact ; Internal ; Talks ;
|
The primary interests of our lab are design and synthesis of biomaterials, and exploring their biomedical applications. The long-term goals of our research are to develop cancer targeted nano-sized drug carrier to eradicate cancer and to design novel drug formulation to alleviate central nervous system (CNS) diseases. Currently, our foci are rational design, and synthesis environment responsive polymers, and fabricating them into cancer or CNS targeted nanoparticle for chemotherapy or gene therapy. |
